Anthem Biosciences is launching its IPO worth ₹3,395 crore, which is entirely an Offer for Sale (OFS) of 5.96 crore shares by existing shareholders. The IPO opens for subscription on July 14, 2025, and will close on July 16, 2025. The allotment of shares is expected to be finalized on July 17, 2025 and the shares are likely to be listed on the BSE and NSE on July 21, 2025. The price band for the IPO is set between ₹540 to ₹570 per share and the lot size is 26 shares.
About Anthem Biosciences IPO
Founded in 2006, Anthem Biosciences is a fast-growing Indian company that helps pharmaceutical and biotech firms develop and manufacture new drugs. It acts as a CRDMO offering end-to-end services across the drug lifecycle: from early discovery to final manufacturing.
The company works with a wide range of global clients from small biotech startups to large pharmaceutical giants in over 44 countries including the U.S., Europe, and Japan.
Anthem specializes in producing fermentation based products like probiotics, enzymes, peptides, and biosimilars. In just the first half of FY25, it worked on 10 commercial drugs and supported them since the discovery stage.
By September 2024, Anthem was handling 196 active projects including:
- 170 discovery projects
- 132 early-stage drug development projects
- 16 late-stage projects
- 13 commercial manufacturing projects
It holds 8 patents (1 in India, 7 overseas) and has 24 more patent applications pending globally, showing its focus on innovation.
The company employs around 600 professionals, including scientists and engineers with deep expertise in drug research and development.
What makes Anthem stand out?
- Offers everything under one roof: drug discovery to manufacturing.
- Focuses heavily on innovation and advanced technology.
- Tailored services for small and mid-size pharmaceutical firms.
- Strong, long-term relationships with loyal clients worldwide.
- Led by a skilled leadership team and top scientific talent.
Anthem Biosciences IPO Highlights
- Anthem Biosciences’s IPO is valued at ₹3,395.00 Cr and the price band is set between ₹540 to ₹570
- The IPO is OFS of 5.96 Cr shares aggregating to ₹3,395.00 cr.
- Anthem Biosciences’s IPO will open for subscription on July 14, 2025 and close onJuly 16, 2025. Share allotment is likely to take place on July 17, 2025 and the shares are expected to be listed on BSE and NSE on July 21, 2025.
- Promoters currently hold 76.87% of the company but after the IPO, their shareholding will come down to 74.68%.
- The company will use net proceeds to repay or reduce company loans, fund fit-out costs and security deposits for new centres, and cover general corporate expenses.
- Kfin Technologies Limited will be the registrar for Anthem Biosciences IPO.
Anthem Biosciences IPO GMP
As of 13th July 2025, Anthem Biosciences’ IPO is trading at a Grey Market Premium (GMP) of ₹100. Based on the upper price band of ₹570, the shares are expected to list at around ₹670. That’s a possible gain of about 17.5% on listing day. This estimate may change, and we’ll keep updating as new details come in.
So, stay tuned with Trade Target for daily updates on Anthem Biosciences IPO GMP and expected listing price.
- Date: 14 July 2025
- Anthem Biosciences GMP: ₹100 ( 17.54%)
- Date: 13 July 2025
- Anthem Biosciences GMP: ₹100 ( 17.54%)
How can one apply for Anthem Biosciences IPO?
Retail investors can apply for minimum of 1 lot, which includes 26 shares costing ₹14,820. Maximum investment allowed for retail investors is 13 lots which totals 338 shares and costs ₹1,92,660.
| Application | Lots | Shares | Amount |
|---|---|---|---|
|
Retail (Min) |
1 |
26 |
₹14,820
|
|
Retail (Max) |
13 |
338 |
₹1,92,660
|
|
S-HNI (Min) |
14 |
364 |
₹2,07,480
|
|
S-HNI (Max) |
67 |
1,742 |
₹9,92,940
|
|
B-HNI (Min)
|
68 |
1,768 |
₹10,07,760
|
Anthem Biosciences IPO Financial
As of March 31, 2025, Anthem Biosciences Ltd. reported a 23% increase in Profit After Tax (PAT), rising from ₹367.31 crore in FY24 to ₹451.26 crore in FY25, indicating steady growth in profitability. All related financial details are provided in the table below.
| Period Ended | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
|
Assets (₹ Crores) |
2,807.58
|
2,398.11
|
2,014.46 |
|
Revenue (₹ Crores) |
1,930.29
|
1,483.07
|
1,133.99
|
|
PAT (₹ crores)
|
451.26
|
367.31
|
385.19
|
|
EBITA(₹ Crores) |
683.78
|
519.96
|
446.05
|
|
Net Worth (₹ Crores) |
2,409.86
|
1,924.66
|
1,740.67
|
|
Reserves and Surplus (₹ crores)
|
2,298.05
|
1,815.39
|
1,628.88
|
|
Total Borrowing (₹ crores)
|
108.95
|
232.53
|
125.06 |
Anthem Biosciences IPO Vs Peer
Anthem Biosciences has reported a basic EPS of ₹8.07. While its P/E ratio is not yet available, the table below compares it with key industry peers, offering insight into its position in the pharmaceutical and contract research space.
| Company | EPS Diluted | P/E(x) |
|---|---|---|
|
Anthem Biosciences Limited
|
8.07
|
– |
|
Syngene International Ltd |
12.35
|
51.54
|
|
Sai Life Sciences Limited |
8.83 |
92.18
|
|
Cohance Lifesciences Limited |
10.52
|
97.29
|
|
DIVI'S LABORATORIES Limited |
82.53
|
83.22
|
Anthem Biosciences IPO Quota Allocation
- QIB Investors: 50% of the net issue
- Retail Investors: 35% of the net issue
- NII (HNI) Investors: 15% of the net issue
Listing Date of Anthem Biosciences IPO
- Subscription Period: 14 July to 16 July 2025
- Basis of Allotment Finalization: 17 July 2025
- Initiation of Refunds: 18 July 2025
- Demat Credits: 18 July 2025
- Listing Date: 21 July 2025
- Listing on: NSE, BSE
Anthem Biosciences IPO FAQs (Frequently Asked Questions)
What is the total issue size of Anthem Biosciences’s IPO?
The total size of Anthem Biosciences’s IPO is ₹3,395.00 Cr.
When will Anthem Biosciences IPO open and close?
Anthem Biosciences’s IPO will open for subscription on 14 July 2025 and close on 16 July 2025.
What is the lot size for Anthem Biosciences IPO?
Retail Investors can bid for a minimum of 1 lot, which includes 26 shares. And one lot will cost you around ₹14,820.
What is the share allotment date for Anthem Biosciences IPO?
The allotment of shares is expected to be completed by 17 July 2025.
Who is the registrar of Anthem Biosciences IPO?
Kfin Technologies Limited is the official registrar for Anthem Biosciences’s IPO.
Where will Anthem Biosciences shares be listed?
The shares are planned to be listed on both BSE and NSE.
Happy investing and thank you for reading!
Disclaimer:
This website content is only for educational purposes, not investment advice. Before making any investment, it’s important to do your own research and be fully informed. Investing in the stock market includes risks, and you should carefully read the Risk Disclosure documents before proceeding. Please remember that past performance doesn’t guarantee future results, and due to market fluctuations, your investment goals may not always be achieved.
